Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5568172 | Heart & Lung: The Journal of Acute and Critical Care | 2016 | 4 Pages |
Abstract
Cited reasons for the use of CRRT for salicylate toxicity primarily have been hypotension or desire for ongoing augmentation of salicylate clearance in the setting of multiorgan toxicity. CVVHDF may have a role in severe salicylate toxicity to enhance ongoing clearance after an initial round of HD in order to prevent significant rebound.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michael F. MD, Margaret MD, Michel MD, Samuel Z. MD,